Abstract
Between February 1995 and September 2004, 47 patients (53 lesions) with primary ocular adnexal MALT lymphoma were treated with radiotherapy. The median dose delivered was 30Gy/20F. Lens shielding was used in 11 patients. Local control rate was 98%. 3, 5 years OAS (overall survival) and RFS (relapse-free survival) were 100%. 100% and 100%, 88%. respectively. Cataracts developed in 17%. Radiotherapy achieved excellent local control and survival rates in the management of primary ocular adnexal MALT lymphoma. Late adverse effects were tolerable.
Original language | English |
---|---|
Pages (from-to) | 1794-1797 |
Number of pages | 4 |
Journal | Japanese Journal of Clinical Radiology |
Volume | 50 |
Issue number | 13 |
Publication status | Published - 2005 |
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging